| Study to Evaluate Improvements of the Quality of Sleep With NOVANUIT® Triple Action in Healthy Volunteers With Sleep Disorders (NCT03514732) | Sanofi | 2017-03-17 |
| Bioequivalence Study Between GSK3542503 Hydrochlorothiazide + Amiloride Hydrochloride 50 mg: 5 mg Tablets and Reference Product in Healthy Adult Participants Under Fasting Conditions (NCT03031496) | GlaxoSmithKline | 2017-03-17 |
| STAT Inhibitor OPB-111077, Decitabine and Venetoclax in Treating Patients With Acute Myeloid Leukemia That Is Refractory, Relapsed or Newly Diagnosed and Ineligible for Intensive Chemotherapy (NCT03063944) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2017-03-17 |
| Variability of Sulfotransferase 1A1 Activity in Humans: an Approach to Improve Predictive Drug Response - Part I: Analysis of Intraindividual Variation in Healthy Adults (NCT03182595) | Hospital da Luz, Portugal | 2017-03-17 |
| Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies (NCT04308330) | New York Medical College | 2017-03-17 |
| Trial of Ginsenoside Compound K (GCK) Tablet in Patients With Rheumatoid Arthritis (NCT03755258) | Zhejiang Hisun Pharmaceutical Co. Ltd. | 2017-03-16 |
| OTR Tablet 40 mg Fed-state Bioequivalence Study (NCT03398330) | Mundipharma (China) Pharmaceutical Co. Ltd | 2017-03-16 |
| Phase Ib/II Trial of Interleukin-2 and PD-1 Checkpoint Inhibitor, Nivolumab In Metastatic Clear Cell Renal Cell Cancer (NCT02989714) | University of Michigan Rogel Cancer Center | 2017-03-16 |
| Single Dose Study to Assess the Safety, Tolerability and Pharmacokinetics(PK) of PF-06865571 (NCT03092232) | Pfizer | 2017-03-16 |
| A Study to Evaluate Safety and Immunogenicity of 1 Booster Dose of 1790GAHB Vaccine in Healthy Adults Primed With 3 Doses of 1790GAHB Vaccine in Study H03_01TP Compared to 1 Vaccination of 1790GAHB in Either Subjects Who Received Placebo in the Same Study or naïve Subjects Not Part of H03_01TP Study (NCT03089879) | GlaxoSmithKline | 2017-03-16 |
| Investigation of the Absorption, Metabolism, and Excretion and the Absolute Bioavailability of YH12852 (NCT03381703) | Seoul National University Hospital | 2017-03-16 |
| Bioequivalence Study of Pramipexole Dihydrochloride Extended-release Tablets in Healthy Chinese Subjects (NCT07519278) | Haisco Pharmaceutical Group Co., Ltd. | 2017-03-16 |
| Determination the Abuse Potential of Pitolisant in Healthy, Non-Dependent Recreational Stimulant Users (NCT03152123) | Bioprojet | 2017-03-15 |
| Evaluation of the Effect of Late Boost on HIV-uninfected Vaccines From EV06 Trial (NCT03391375) | EuroVacc Foundation | 2017-03-15 |
| Topical Menthol +/- Mannitol for Painful Diabetic Peripheral Neuropathy (NCT02728687) | University of British Columbia | 2017-03-15 |
| Drug-drug Interaction Study Between UIC201603, and UIC201604 (NCT06568133) | Korea United Pharm. Inc. | 2017-03-15 |
| Phase I Study of S64315 Administred Intravenously in Patients With Acute Myeloid Leukaemia or Myelodysplastic Syndrome (NCT02979366) | Institut de Recherches Internationales Servier | 2017-03-15 |
| Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit (NCT02863809) | Joseph B. Ciolino, MD | 2017-03-15 |
| A Study to Determine the Safety and Immunogenicity of a Candidate MAP Vaccines ChAdOx2 HAV and MVA in Healthy Adult Volunteers (NCT03027193) | University of Oxford | 2017-03-15 |
| TRT in Combination With Electrical Stimulation and Standing: Effect on Muscle and Bone in Spinal Cord Injured Males (NCT02317640) | Kessler Foundation | 2017-03-15 |
| A Dye for the Detection of Cancer of the Tongue and Mouth (NCT03085147) | Memorial Sloan Kettering Cancer Center | 2017-03-15 |
| A Study of LY3337641 in Japanese and Caucasian Healthy Participants (NCT03083561) | Eli Lilly and Company | 2017-03-15 |
| A Study of ACT-541468 in Healthy Japanese and Caucasian Subjects (NCT03101189) | Idorsia Pharmaceuticals Ltd. | 2017-03-15 |
| Ceramide NanoLiposome in Patients With Advanced Solid Tumors (NCT02834611) | Keystone Nano, Inc | 2017-03-15 |
| A Trial of "Armored" CAR T Cells Targeting CD19 For Patients With Relapsed CD19+ Hematologic Malignancies (NCT03085173) | Memorial Sloan Kettering Cancer Center | 2017-03-15 |
| Evaluation of Safety and Efficacy of BBI-2000 in Treating and Preventing Contact Dermatitis (NCT03089775) | Fresh Tracks Therapeutics, Inc. | 2017-03-14 |
| Interaction Study to Evaluate the Effects of Mefenamic Acid on the Pharmacokinetics and Pharmacodynamics of Sotagliflozin in Healthy Male and Female Subjects (NCT03070678) | Sanofi | 2017-03-14 |
| A Study to Evaluate the Effect of Oral Doses of JNJ-54175446 on the Inhibition of Cytochrome P450 CYP3A4, CYP2C9, CYP1A2 and CYP2D6 Activity and the Induction of CYP2B6 and CYP2C19 Activity Using a Multiple Probe Substrate Cocktail in Healthy Subjects (NCT03058419) | Janssen Research & Development, LLC | 2017-03-14 |
| A Study to Determine the Effect of Food on the Pharmacokinetics of Erdafitinib in Healthy Participants (NCT03066687) | Janssen Research & Development, LLC | 2017-03-14 |
| Pembrolizumab and Carboplatin in Treating Patients With Relapsed or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT03029598) | University of Washington | 2017-03-14 |
| Evaluation of MDMA on Startle Response (NCT03181763) | Resilient Pharmaceuticals | 2017-03-14 |
| Evaluate the PK, Safety, Tolerability of Ferric Maltol at 3 Dosage Levels in Paediatric Subjects With Iron Deficiency (NCT03181451) | Shield Therapeutics | 2017-03-14 |
| Pharmacokinetic Single Dose Study of Oral Lasmiditan in Participants With Normal and Impaired Hepatic Function (NCT03040479) | Eli Lilly and Company | 2017-03-14 |
| A Single-dose Study in Paediatric Patients Aged 2 to Less Than 18 Years With Secondary Hyperparathyroidism (sHPT) Receiving Haemodialysis (NCT02833857) | Amgen | 2017-03-14 |
| Stem Cell Fistula Plug in Post Surgical Leak Fistulas (NCT02807389) | Mayo Clinic | 2017-03-14 |
| CiPA Phase 1 ECG Biomarker Validation Study (NCT03070470) | Food and Drug Administration (FDA) | 2017-03-14 |
| Pembrolizumab With Nab-Paclitaxel in Non-Small Cell Lung Cancer (NCT02733250) | Centre hospitalier de l'Université de Montréal (CHUM) | 2017-03-13 |
| The Effect of Autologous Stromal Vascular Fractions on Skin Regeneration (NCT03189628) | Shanghai Jiao Tong University School of Medicine | 2017-03-13 |
| Diagnostic Utility of F-18 Florbetapir PET/MR in Peripheral Nerve Amyloidosis (NCT03019029) | Mayo Clinic | 2017-03-13 |
| Bioequivalence Study Comparing Single Dose of Ferrinemia® Injection With a Single Dose of Venofer® Injection in Healthy Male Volunteers (NCT03093883) | Azad Pharma AG | 2017-03-13 |
| Evaluating PK, Tolerability, and Safety of Rifapentine and Isoniazid in Pregnant and Postpartum Women (NCT02651259) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-03-13 |
| The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists (NCT03049462) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2017-03-13 |
| Administration of Clomiphene: Short and Long Term Metabolism in an Anti-Doping Setting (NCT03028532) | Stuart Willick | 2017-03-13 |
| Study to Compare the Pharmacokinetics of AC 1202 and Two Doses of AC-SD-01 on Ketone Body Production (NCT03063645) | Cerecin | 2017-03-11 |
| Nivolumab With or Without Stereotactic Radiosurgery in Treating Patients With Recurrent, Advanced, or Metastatic Chordoma (NCT02989636) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-03-10 |
| Robotics for Mobility Rehabilitation in MS (NCT05102682) | East Kent Hospitals University NHS Foundation Trust | 2017-03-10 |
| Safety and Efficacy Study of Daily SPL-108 Injections In Conjunction With Paclitaxel in Women With Ovarian Cancer (NCT03078400) | Splash Pharmaceuticals, Inc. | 2017-03-10 |
| Use of Sildenafil for Treatment of Urinary Incontinence (NCT02983461) | The University of Texas Medical Branch, Galveston | 2017-03-10 |
| MEN1703 (SEL24) in Participants With Acute Myeloid Leukemia (NCT03008187) | Menarini Group | 2017-03-10 |
| Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery (NCT03009201) | OHSU Knight Cancer Institute | 2017-03-10 |
| Ibrutinib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Ineligible for Transplant (NCT03015792) | Mayo Clinic | 2017-03-10 |
| Study of Targeted Therapy Using Transcription Activator-like Effector Nucleases in Cervical Precancerous Lesions (NCT03226470) | Huazhong University of Science and Technology | 2017-03-10 |
| Low-cost Enabling Technology for Image-guided Photodynamic Therapy (PDT) of Oral Cancer Cancer. (NCT03638622) | Massachusetts General Hospital | 2017-03-10 |
| Combination Study of Prexasertib and Olaparib in Patients With Advanced Solid Tumors (NCT03057145) | Geoffrey Shapiro, MD, PhD | 2017-03-10 |
| Safety and Tolerance of Immunomodulating Therapy With Donor-specific MSC in Pediatric Living-Donor Liver Transplantation (NCT02957552) | University Hospital Tuebingen | 2017-03-10 |
| A Study of Fluzoparib Given in Combination With Apatinib in Ovarian or Breast Cancer Patients (NCT03075462) | Jiangsu HengRui Medicine Co., Ltd. | 2017-03-09 |
| Compare IBI305 and Bevacizumab on Pharmacokinetics/Safety/Immunogenicity on Healthy Male (NCT03083990) | Innovent Biologics (Suzhou) Co. Ltd. | 2017-03-09 |
| Adoptive Transfer of Haploidentical Natural Killer Cells and IL-2 (NCT03346499) | University of Minnesota | 2017-03-09 |
| F16IL2 in Combination With Nivolumab in Patients With Non-small Cell Lung Cancer (NCT05468294) | Philogen S.p.A. | 2017-03-09 |
| CART-PSMA-TGFβRDN Cells for Castrate-Resistant Prostate Cancer (NCT03089203) | University of Pennsylvania | 2017-03-08 |
| A Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa Using BIIB112 (NCT03116113) | Biogen | 2017-03-08 |
| A Study of the Abuse Liability Potential of Cenobamate in Recreational Drug Users (NCT03509285) | SK Life Science, Inc. | 2017-03-08 |
| Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma (NCT03011814) | City of Hope Medical Center | 2017-03-08 |
| Oncolytic MG1-MAGEA3 With Ad-MAGEA3 Vaccine in Combination With Pembrolizumab for Non-Small Cell Lung Cancer Patients (NCT02879760) | Turnstone Biologics, Corp. | 2017-03-08 |
| A Study of SC-006 and in Combination With ABBV-181 in Subjects With Advanced Colorectal Cancer (NCT03035279) | AbbVie | 2017-03-08 |
| A Clinical Trial of BAT8001 on Safety, Tolerability and Pharmacokinetics for Patients (NCT04189211) | Bio-Thera Solutions | 2017-03-07 |
| A Phase I/Ib Study of MEK162, a MEK Inhibitor, in Combination With Carboplatin and Pemetrexed in Patients With Non-squamous Carcinoma of the Lung (NCT02185690) | University Health Network, Toronto | 2017-03-07 |
| A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia B (NCT03075670) | Novo Nordisk A/S | 2017-03-07 |
| Study to Evaluate the Safety/ Efficacy of T-VEC in Japanese Subjects With Unresectable Stage IIIB-IV Malignant Melanoma (NCT03064763) | Amgen | 2017-03-07 |
| A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (NCT03093116) | Turning Point Therapeutics, Inc. | 2017-03-07 |
| A Study Evaluating Venetoclax Alone and in Combination With Azacitidine in Participants With Relapsed/Refractory Myelodysplastic Syndromes (MDS) (NCT02966782) | AbbVie | 2017-03-07 |
| A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MM (NCT02886065) | Massachusetts General Hospital | 2017-03-07 |
| Taladegib, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Localized Esophageal or Gastroesophageal Junction Cancer (NCT02530437) | M.D. Anderson Cancer Center | 2017-03-07 |
| Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 (NCT03210649) | Chong Kun Dang Pharmaceutical | 2017-03-07 |
| DP13 SAD & MAD in Healthy Male Subjects (NCT03046589) | Damian Pharma AG | 2017-03-06 |
| A Trial to Assess Safety and Efficacy of Topical MBN-101 in Patients With Moderate/ Severe DFI (NCT02723539) | Microbion Corporation | 2017-03-06 |
| A Study of LY3192767 in Healthy Participants (NCT03025009) | Eli Lilly and Company | 2017-03-06 |
| Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPS201 in NETs (NCT02592707) | Ipsen | 2017-03-06 |
| A Phase 1 Study Evaluating the Safety of TRK-950 in Patients With Advanced Solid Tumors (NCT02990481) | Toray Industries, Inc | 2017-03-06 |
| Ensartinib in Non-small Cell Lung Cancer Patients With Positive ALK (NCT02959619) | Betta Pharmaceuticals Co., Ltd. | 2017-03-06 |
| Study of Ixazomib and Erlotinib in Solid Tumors (NCT02942095) | M.D. Anderson Cancer Center | 2017-03-06 |
| Fosbretabulin With Everolimus in Neuroendocrine Tumors With Progression (NCT03014297) | Lowell Anthony, MD | 2017-03-06 |
| Stereotactic Body Radiation Therapy Combined With Anti-PD-1 Antibody in Metastatic Triple Negative Breast Cancer (NCT03151447) | Fudan University | 2017-03-06 |
| A Multiple Ascending Dose Study to Evaluate Safety and Tolerability of BFKB8488A in Participants With Type 2 Diabetes Mellitus and Participants With Non-Alcoholic Fatty Liver Disease (NCT03060538) | Genentech, Inc. | 2017-03-05 |
| A Study of TAK-659 in Combination With Bendamustine (+/-Rituximab), Gemcitabine, Lenalidomide, or Ibrutinib for the Treatment of Participants With Advanced Non-Hodgkin Lymphoma (NCT02954406) | Millennium Pharmaceuticals, Inc. | 2017-03-05 |
| QUILT-3.013: Study of Ad5 [E1-, E2b-]-HER2/Neu Vaccine (ETBX-021) in Subjects With Unresectable Locally Advanced or Metastatic HER2-Expressing Breast Cancer (NCT02751528) | NantBioScience, Inc. | 2017-03-04 |
| The Neurobiological Effect of 5-HT2AR Modulation (NCT03289949) | Gitte Moos Knudsen | 2017-03-03 |
| A Repeated Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease (NCT03093519) | Kyowa Kirin Co., Ltd. | 2017-03-03 |
| Evaluating the Safety and Efficacy of Oral Encapsulated Fecal Microbiota Transplant in Peanut Allergic Patients (NCT02960074) | Rima Rachid | 2017-03-03 |
| Pharmacokinetics of Nalbuphine After Intravenous and Intranasal Administration in Infants (NCT03059511) | University Children's Hospital, Zurich | 2017-03-03 |
| Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E6742 in Healthy Adult Subjects (NCT03082235) | Eisai Inc. | 2017-03-03 |
| Safety, PK and Efficacy of NOX66 as a Monotherapy and Combined With Carboplatin in Refractory Solid Tumours (NCT02941523) | Noxopharm Limited | 2017-03-03 |
| Tolerance Study of the Dietary Supplement Lipidrive (ECPH1-03) (NCT03052062) | Valbiotis | 2017-03-02 |
| Subconjunctival Aflibercept (EYLEA®) for the Treatment of Corneal Neovascularization (NCT02797704) | Rabin Medical Center | 2017-03-02 |
| Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05) (NCT02658968) | Nordic Nanovector | 2017-03-02 |
| Study to Assess the Effect of Osimertinib (TAGRISSO™ ) on Blood Levels of Fexofenadine in Patients With EGFRm+ NSCLC (NCT02908750) | AstraZeneca | 2017-03-02 |
| Fish Oil vs. Placebo on Subjective Effects of Alcohol (NCT03010917) | Yale University | 2017-03-02 |
| Immune Response and General Immune Health in Subjects Infected With Herpes Simplex Virus Type 1 (HSV-1) (NCT03661541) | Squarex, LLC | 2017-03-02 |
| A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in R/R ALL and Lymphoma Subjects (NCT03156101) | Shenzhen BinDeBio Ltd. | 2017-03-02 |
| Optimal Fecal Microbiota Transplant Dosing for Mild to Moderate Ulcerative Colitis (NCT03006809) | Najwa Elnachef | 2017-03-02 |